642 related articles for article (PubMed ID: 27773425)
1. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F
Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266
[TBL] [Abstract][Full Text] [Related]
3. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition.
Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW
Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927
[TBL] [Abstract][Full Text] [Related]
4. A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy.
Bonaud A; Bender S; Touchard G; Lacombe C; Srour N; Delpy L; Oblet C; Druilhe A; Quellard N; Javaugue V; Cogné M; Bridoux F; Sirac C
Blood; 2015 Aug; 126(6):757-65. PubMed ID: 26113545
[TBL] [Abstract][Full Text] [Related]
5. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
Joly F; Cohen C; Javaugue V; Bender S; Belmouaz M; Arnulf B; Knebelmann B; Nouvier M; Audard V; Provot F; Gnemmi V; Nochy D; Goujon JM; Jaccard A; Touchard G; Fermand JP; Sirac C; Bridoux F
Blood; 2019 Feb; 133(6):576-587. PubMed ID: 30578255
[TBL] [Abstract][Full Text] [Related]
6. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
[TBL] [Abstract][Full Text] [Related]
8. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
9. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.
Gallo G; Picken M; Frangione B; Buxbaum J
Mod Pathol; 1988 Nov; 1(6):453-6. PubMed ID: 3146753
[TBL] [Abstract][Full Text] [Related]
10. A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy.
Oe Y; Nakaya I; Yahata M; Sakuma T; Sato H; Soma J
Intern Med; 2010; 49(14):1411-5. PubMed ID: 20647658
[TBL] [Abstract][Full Text] [Related]
11. Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
Alexander MP; Nasr SH; Watson DC; Méndez GP; Rennke HG
Am J Kidney Dis; 2011 Oct; 58(4):621-5. PubMed ID: 21944962
[TBL] [Abstract][Full Text] [Related]
12. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
Zhang Y; Li X; Liang D; Xu F; Liang S; Zhu X; Zheng N; Huang X; Liu Z; Zeng C
Am J Kidney Dis; 2020 May; 75(5):736-743. PubMed ID: 31699519
[TBL] [Abstract][Full Text] [Related]
13. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease.
Soma J; Tsuchiya Y; Sakuma T; Sato H
Clin Nephrol; 2008 May; 69(5):383-6. PubMed ID: 18538103
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia.
Soma J; Sato K; Sakuma T; Saito H; Sato H; Sato T; Abbas A; Aucouturier P
Am J Kidney Dis; 2004 Jan; 43(1):E10-6. PubMed ID: 14712467
[TBL] [Abstract][Full Text] [Related]
15. IgG heavy-chain deposition disease.
Katz A; Zent R; Bargman JM
Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
[TBL] [Abstract][Full Text] [Related]
16. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype.
Herzenberg AM; Kiaii M; Magil AB
Am J Kidney Dis; 2000 May; 35(5):E25. PubMed ID: 10793054
[TBL] [Abstract][Full Text] [Related]
17. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
Komatsuda A; Ohtani H; Sawada K; Joh K; Wakui H
Pathol Int; 2013 Jan; 63(1):63-7. PubMed ID: 23356227
[TBL] [Abstract][Full Text] [Related]
18. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
[TBL] [Abstract][Full Text] [Related]
19. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases.
Patel K; Dillon JJ; Leung N; Bomback AS; Appel GB; D'Agati V; Canetta PA
Am J Kidney Dis; 2014 Jul; 64(1):123-7. PubMed ID: 24613055
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications.
Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC
Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
